Grand Medical (Europe)

Grand Medical (Europe)

Foundation date

16/04/2021

Sector

#Pharma

Subsector

• #Therapeutics - Peptides
• #Therapeutics - Proteins
• #Other - Industrial Biotechnology
• #Pharma - Anti-infectives
• #Pharma - Gene therapy
• #Pharma - Generics
• #Pharma - Small molecule therapeutics
• #Pharma - Vaccines

Therapeutic areas

• #Cardiovascular
• #Conditions originating in the perinatal period
• #Digestive system
• #Neoplasms / cancer / oncology
• #Respiratory system

Grand Medical Europe (GME) is a newly established Belgian subsidiary of China Grand Pharmaceutical & Healthcare Holdings Limited (CGP). CGP ranks among China top Pharma and develops products and medical devices in respiratory, cardio/cerebrovascular, antiviral, anti-infection, oncology, ophthalmology, ENT, amino acids, CNS fields. GME is focusing on R&D collaboration with Belgian & European institutions and wishes to explore commercial cooperation with companies interested in the Chinese market.